TDAC
NASDAQ · N/A
Translational Development Ac
$10.57
-0.01 (-0.09%)
Open$10.57
Previous Close$10.58
Day High$10.58
Day Low$10.56
52W High$10.56
52W Low$10.03
Volume—
Avg Volume8.8K
Market Cap230.91M
P/E Ratio48.52
EPS$0.22
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 211.68M | 197.91M | 234.06M |
| Net Income | 7.59M | 7.31M | 8.97M |
| Profit Margin | 3.6% | 3.7% | 3.8% |
| EBITDA | 13.67M | 12.28M | 15.52M |
| Free Cash Flow | 6.88M | 4.06M | 6.97M |
| Rev Growth | +3.0% | +7.4% | -1.8% |
| Debt/Equity | 0.09 | 0.09 | 0.09 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $8.24 | +8.56% | — | 4.06B |
| PICS | Pics Nv | $10.45 | +5.34% | — | 2.04B |
| DMII | Drugs Made In America Acquis | $9.97 | -0.10% | — | 656.41M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.18B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.56 | -0.14% | 63.3 | 608.01M |
| CEPF | Cantor Equity Partners-Cl A | $10.19 | -0.10% | 356.1 | 583.50M |